Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06331598
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-03-19
Brief Title:
A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors With Resectable Disease With Intermediate-High Risk of Recurrence and High Tumor Mutational Burden TMB-H or Microsatellite Instability MSI-H
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumors |
Keywords: